Ashland Inc. (ASH) AI Stock Analysis

Ashland Inc., headquartered in Wilmington, Delaware, is a global provider of additives and specialty ingredients. Founded in 1924, the company operates across four key segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences provides pharmaceutical solutions including controlled release polymers, disintegrants, tablet coatings, and binders, alongside nutrition solutions like thickeners, stabilizers, and nutraceutical products. Personal Care offers nature-based ingredients for oral care, household supplies, and personal care products, including biodegradable surface wetting agents and specialty polymers. Specialty Additives provides advanced materials such as rheology modifiers, foam control agents, and surfactants used in environmental filters, textile printing, and electronics manufacturing.

Ashland experienced declining top-line performance in recent fiscal years, falling from peak revenue of $2.39B in FY2022 to $2.19B in FY2023, $2.11B in FY2024, and $1.82B in FY2025, reflecting a revenue contraction of 13.7% in FY2025. Operating margin dropped to -42.5% in FY2025, resulting in a net loss of -$845.0M. Over the 5-year period from FY2020 to FY2025, revenue posted a CAGR of -2.0%. For the trailing twelve months ended June 30, 2026, revenue stood at $1.84B with EPS of $1.56. In the latest quarter ended June 30, 2026, quarterly revenue grew 7.3% year-over-year, while quarterly earnings declined 47.5%.

As of June 30, 2026, Ashland held $440.0M in cash and short-term investments against total debt of $1.48B, yielding net debt of $1.04B. Shareholders' equity was $1.87B, with a debt-to-equity ratio of 0.79 and a current ratio of 3.05. In FY2025, operating cash flow was $94.0M, while free cash flow was -$4.0M after capital expenditures of $98.0M. During FY2025, the company deployed $100.0M toward share buybacks and paid $76.0M in dividends, contributing to a 5-year share count change of -20.7%.

At a last close price of $71.15, Ashland carries a market capitalization of $3.26B and an enterprise value of $4.20B. The stock trades at a trailing P/E of 45.6x, above the 19.7x median of its US-listed Basic Materials peers. Its forward P/E is 15.7x compared to the peer median of 13.4x, and its EV/EBITDA is 11.2x versus the peer median of 10.5x. Over the past year, ASH gained 49.4%, outperforming the S&P 500 (SPY) return of 16.8%, but its 5-year return of -17.8% trails the index gain of 83.0%.

Ashland pays an annual forward dividend of $1.68 per share, representing a dividend yield of 2.36% and a payout ratio of 51.1%. Dividends are distributed quarterly and have been paid for 44 consecutive years. Over the past 5 years, dividend growth annualized at 8.4%. The most recent ex-dividend date was September 1, 2026.

Wall Street coverage includes 8 Strong Buy, 1 Buy, and 3 Hold ratings, with no Sell or Strong Sell ratings. The mean price target is $80.36, representing a 12.9% premium over the last close of $71.15. For the fiscal year ending September 30, 2026, consensus estimates project revenue of $1.86B and EPS of $3.52. For the following fiscal year, 11 analysts estimate revenue of $1.93B and EPS of $4.32. Ashland has beaten EPS estimates in 1 of the last 4 quarters, with next earnings scheduled for November 3, 2026.

This page is an AI-written research summary of Ashland Inc. (ASH). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: ASH income statement, ASH balance sheet, ASH key metrics, ASH analyst forecast, ASH chart. See the ASH stock overview for the latest quote and news.